Sign In
Buy ASND
$243.91
-7.16 (-2.85%)
At Close: Jul 31, 2026
Ascendis Pharma A/S Expected to Post FY2023 Earnings of $0.36 Per Share (NASDAQ:ASND)
06:54am, Monday, 06'th Apr 2020
Ascendis Pharma A/S (NASDAQ:ASND) – Research analysts at Oppenheimer boosted their FY2023 earnings per share estimates for shares of Ascendis Pharma A/S in a report released on Thursday, April 2nd.
Franklin Resources Inc. Sells 59,492 Shares of Ascendis Pharma A/S (NASDAQ:ASND)
10:26am, Saturday, 04'th Apr 2020
Franklin Resources Inc. lessened its holdings in shares of Ascendis Pharma A/S (NASDAQ:ASND) by 6.8% in the fourth quarter, HoldingsChannel.com reports. The firm owned 818,742 shares of the biotechnol
Ascendis Pharma A/S (NASDAQ:ASND) Stock Rating Lowered by Zacks Investment Research
07:26am, Saturday, 04'th Apr 2020
Ascendis Pharma A/S (NASDAQ:ASND) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a note issued to investors on Thursday, Zacks.com reports. According to
Wedbush Maintains a Buy Rating on Ascendis Pharma (ASND)
10:25pm, Thursday, 02'nd Apr 2020
Wedbush analyst Liana Moussatos maintained a Buy rating on Ascendis Pharma (ASND) today and set a price target of $186.00. The company's shares closed
Wedbush Maintains a Buy Rating on Ascendis Pharma (ASND)
10:25pm, Thursday, 02'nd Apr 2020
Wedbush analyst Liana Moussatos maintained a Buy rating on Ascendis Pharma (ASND – Research Report) today and set a price
Analysts Offer Insights on Healthcare Companies: Arena Pharma (ARNA) and Ascendis Pharma (ASND)
06:44pm, Thursday, 02'nd Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Arena Pharma (ARNA) and Ascendis Pharma (ASND) with bullish
Analysts Offer Insights on Healthcare Companies: Arena Pharma (NASDAQ: ARNA) and Ascendis Pharma (NASDAQ: ASND)
06:44pm, Thursday, 02'nd Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Arena Pharma
Wall Street Analysts Are Bullish on Top Healthcare Picks
05:06pm, Thursday, 02'nd Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Eli Lilly & Co (LLY), Ascendis Pharma (ASND) and
Edited Transcript of ASND earnings conference call or presentation 1-Apr-20 8:30pm GMT
01:44pm, Thursday, 02'nd Apr 2020
Q4 2019 Ascendis Pharma A/S Earnings Call
Analysts' Top Healthcare Picks: Hologic (HOLX), Ascendis Pharma (ASND)
09:44am, Thursday, 02'nd Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Hologic (HOLX) and Ascendis Pharma (ASND) with bullish
Analysts’ Top Healthcare Picks: Hologic (HOLX), Ascendis Pharma (ASND)
09:44am, Thursday, 02'nd Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Hologic (HOLX
Ascendis Pharma A/S (ASND) CEO Jan Mikkelsen on Q4 2019 Results - Earnings Call Transcript
08:35am, Thursday, 02'nd Apr 2020
Ascendis Pharma A/S (NASDAQ:ASND) Q4 2019 Earnings Conference Call April 1, 2020 16:30 ET Company Participants Scott Smith - Senior Vice President and Chief Fin
Ascendis Pharma A/S (ASND) Q4 2019 Earnings Call Transcript
05:30am, Thursday, 02'nd Apr 2020
ASND earnings call for the period ending December 31, 2019.
Gilde Healthcare Raises €416M Venture And Growth Capital Fund
09:38pm, Wednesday, 01'st Apr 2020
Utrecht (the Netherlands), Cambridge, Massachusetts (USA) – based Gilde Healthcare closed Gilde Healthcare V, a €416m ($450m) venture and growth capital fund
Ascendis Pharma A/S Reports Full-Year 2019 Financial Results
08:01pm, Wednesday, 01'st Apr 2020
– On track with 2020 corporate milestones – – Top-line data from PaTH Forward phase 2 trial on track for mid-April – – Conference call today at 4:30 p.m. Eastern.
